Le Lézard
Classified in: Health
Subject: FDA

Thornhill Medical's MOVES® SLCtm Portable Emergency Life Support System Receives 510K Clearance From The US FDA


TORONTO, June 8, 2017 /PRNewswire/ -- Thornhill Medical, has received notification from the US FDA that the MOVES® SLCtm Portable Emergency Life Support System has received 510K clearance. This approval expands the capabilities of the current MOVES® SLCtm system, including Pediatric Settings, Expanded Patient Monitoring Modes, New Ventilator Modes, and a Remote Monitoring and Control Interface.

Portable Emergency Life Support System

"The US FDA 510K clearance represents a significant milestone in the development of our emergency medical device portfolio. The MOVES® SLCtm has been tested in extreme conditions of temperature, altitude, shock, vibration, EMC, sand, dust, and rain. It has also been fully evaluated by the US Army Aeromedical Research Laboratory at Ft. Rucker (USAARL). As such, the MOVES® SLCtm is the ideal solution for disaster relief, medevac transportation and overflow ICU situations," stated Kipton Lade, President and CEO of Thornhill Medical.

About MOVES® SLCtm

The MOVES® SLCtm Portable Emergency Life Support System is the world's first and only system with a built-in oxygen concentrator. It extracts oxygen from the air to deliver 85% FiO2 concentrations for ventilated patients, without the need for O2 tanks. This helps makes the MOVES® SLCtm system 50% smaller and 60% lighter than standard portable life support systems currently in use.

MOVES® SLCtm includes: a ventilator, an oxygen concentrator, a suction system, and a comprehensive patient vital signs monitoring module.

About Thornhill RMedical

The MOVES® SLCtm Portable Emergency Life Support System is designed and manufactured at Thornhill Medical's ISO 13485 certified facility in Toronto, Ontario, Canada. The company develops and manufactures innovative healthcare devices. The founder, Dr. Joseph Fisher, is a world-renowned research scientist in the field of anesthesiology and cardiovascular intensive care. Since its spin-off from the University Health Network in 2003, Thornhill Medical has built upon Dr. Fisher's expertise in developing compact mobile emergency respiration and anesthesia devices. Our full story can be found on our website, www.thornhillmedical.com

Media Contact:

Kipton Lade
President & CEO
Thornhill Medical
(416) 597-1325
[email protected]

SOURCE Thornhill Medical


These press releases may also interest you

at 09:20
Coronis Health, a trusted partner for laboratory and pathology revenue cycle management (RCM), will be a leading voice at the upcoming Executive War College (EWC) 2024 conference from April 30 to May 1 in New Orleans. As the premier forum for...

at 09:18
PRUVN Research LLC, [PRUVN], a leading research organization validating wellness products and services, is excited to announce the results of its recent preliminary study with Max International, investigating the impact of RiboCeinetm supplementation...

at 09:15
After graduating from Cornell University, Daphni Sawyer worked in healthcare for more than two years before she decided to pursue an advanced degree. In May, she will graduate with two master's degrees from Rutgers. ...

at 09:15
Thirty Madison, the specialty telemedicine company operating Keeps, Cove, and Nurx, today announced a partnership with Talkspace, a  leading online behavioral health company, to expand comprehensive mental health offerings for more than half a...

at 09:15
RevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today it has successfully closed its first seed funding round, raising $16.5 million to propel its mission to develop and...

at 09:15
Evive Brands, a leading name in the health and home services sector, announced today that all four of its flagship brands have been named to FranServe's  FRAN-TASTIC 500 list....



News published on and distributed by: